1. Home
  2. Browse
  3. HRA006322
HRA006322
   HRA006322.xlsx
Title:
Single-cell RNA-seq profiling the heterogeneity of tumor cells and microenvironments in different pathological endometrial cancer
Release date:
2025-12-19
Description:
To better explore the specific characteristics of pathogenesis and tumor microenvironment of different EC samples with different pathological types, we performed scRNA-seq on 18 patients. We comprehensively revealed the heterogeneity in percentage, functional status and cell-cell communication of different cell subpopulations within identified malignant epithelial cells, NK_T cells, fibroblasts, macrophages and endothelial cells (ECs) using the single-cell expression atlas and experimental methods in vitro.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA022185
Study type:
Disease Study
Disease name:
endometrial adenosquamous carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC003497
DAC name:
FAH of ZZU
Contact person:
Ren Fang
Email:
renfang@foxmail.com
Description:
The First Affiliated Hospital of Zhengzhou University is currently the largest Level-3/Grade-A hospital in China which integrates medical treatment, teaching, research, prevention, health care and recuperation. It represents the higher standard of medical care ability, scientific research level, and international communicative competence in domestic. This study was approved by the Medical Ethics Committee of First Affiliated Hospital of Zhengzhou University (Approved number: 2022-KY-1173-002)
Individuals & samples
Files
Request Data
Submitter:   Ren Fang / renfang@foxmail.com
Organization:   The First Affiliated Hospital of Zhengzhou University
Submission date:   2023-12-19
Requests:   8